483 Momenta Pharmaceuticals Jun 2012

483 Momenta Pharmaceuticals Jun 2012

Paraluman Leonin FDA, Kenneth Williams FDA$119.00 - Available Now

FDA investigators audited the Momenta Pharmaceuticals - Cambridge, MA, United States facility and issued inspectional observations (via FDA 483) on 08 Jun 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Jun 2012
  • Location: Cambridge, United States
  • FEI: 3005948218
Add To Cart